FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

Packageus.nlm.vsac
Resource TypeValueSet
IdValueSet-2.16.840.1.113883.3.1444.5.244.json
FHIR VersionR4
Sourcehttps://vsac.nlm.nih.gov/valueset/2.16.840.1.113883.3.1444.5.244/expansion
URLhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.244
Version20241010
Statusactive
Date2024-10-10T01:07:42-04:00
NameAnthracyclineInjectable
TitleAnthracycline Injectable
Realmus
Authorityhl7
DescriptionUsed in: #1045
Purpose(Clinical Focus: The purpose of this value set is to represent concepts of medication anthracycline.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent a medication anthracycline; generic; prescribable; injectable.),(Exclusion Criteria: Excludes concepts that represent non-prescribable branded drugs, components or ingredients.)

Resources that use this resource

No resources found


Resources that this resource uses

CodeSystem
rxnormRxNorm
ValueSet
2.16.840.1.113762.1.4.1116.168Doxorubicin Injectable
2.16.840.1.113762.1.4.1116.200Epirubicin Injectable
2.16.840.1.113762.1.4.1116.332Daunorubicin Injectable
2.16.840.1.113883.3.1444.3.153Idarubicin Injectable
2.16.840.1.113883.3.1444.3.167Mitoxantrone Injectable
2.16.840.1.113883.3.1444.3.197Doxorubicin Pegylated Liposomal Injectable

Narrative

No narrative content found in resource


Source1

{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113883.3.1444.5.244",
  "meta": {
    "versionId": "15",
    "lastUpdated": "2024-10-10T01:07:42.000-04:00",
    "profile": [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueContactDetail": {
        "name": "American Society of Clinical Oncology Author"
      }
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate": "2025-04-08"
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate": "2024-10-10"
    }
  ],
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.244",
  "identifier": [
    {
      "system": "urn:ietf:rfc:3986",
      "value": "urn:oid:2.16.840.1.113883.3.1444.5.244"
    }
  ],
  "version": "20241010",
  "name": "AnthracyclineInjectable",
  "title": "Anthracycline Injectable",
  "status": "active",
  "date": "2024-10-10T01:07:42-04:00",
  "publisher": "American Society of Clinical Oncology Steward",
  "description": "Used in: #1045",
  "jurisdiction": [
    {
      "coding": [
        {
          "system": "urn:iso:std:iso:3166",
          "code": "US"
        }
      ]
    }
  ],
  "purpose": "(Clinical Focus: The purpose of this value set is to represent concepts of medication anthracycline.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent a medication anthracycline; generic; prescribable; injectable.),(Exclusion Criteria: Excludes concepts that represent non-prescribable branded drugs, components or ingredients.)",
  "compose": {
    "include": [
      {
        "valueSet": [
          "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.332"
        ]
      },
      {
        "valueSet": [
          "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.197"
        ]
      },
      {
        "valueSet": [
          "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.168"
        ]
      },
      {
        "valueSet": [
          "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.167"
        ]
      },
      {
        "valueSet": [
          "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.200"
        ]
      },
      {
        "valueSet": [
          "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.153"
        ]
      }
    ]
  },
  "expansion": {
    "identifier": "urn:uuid:5da92564-f0b5-4549-88d1-709a1501b972",
    "timestamp": "2025-05-23T21:57:34-04:00",
    "total": 17,
    "contains": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1191138",
        "display": "doxorubicin hydrochloride 2 MG/ML Injectable Solution"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1732182",
        "display": "25 ML epirubicin hydrochloride 2 MG/ML Injection"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1732186",
        "display": "100 ML epirubicin hydrochloride 2 MG/ML Injection"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1790095",
        "display": "doxorubicin hydrochloride 50 MG Injection"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1790097",
        "display": "5 ML doxorubicin hydrochloride 2 MG/ML Injection"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1790099",
        "display": "10 ML doxorubicin hydrochloride 2 MG/ML Injection"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1790100",
        "display": "25 ML doxorubicin hydrochloride 2 MG/ML Injection"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1790103",
        "display": "doxorubicin hydrochloride 10 MG Injection"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1790115",
        "display": "10 ML doxorubicin hydrochloride liposome 2 MG/ML Injection"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1790127",
        "display": "25 ML doxorubicin hydrochloride liposome 2 MG/ML Injection"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1791493",
        "display": "20 ML idarubicin hydrochloride 1 MG/ML Injection"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1791498",
        "display": "10 ML idarubicin hydrochloride 1 MG/ML Injection"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1791500",
        "display": "5 ML idarubicin hydrochloride 1 MG/ML Injection"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1872062",
        "display": "doxorubicin hydrochloride 20 MG Injection"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "197989",
        "display": "mitoxantrone 2 MG/ML Injectable Solution"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "2002002",
        "display": "10 ML daunorubicin 5 MG/ML Injection"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "309650",
        "display": "4 ML daunorubicin 5 MG/ML Injection"
      }
    ]
  }
}